FREE SHIPPING BOTH WAYSON EVERY ORDER!
|Epidemiology of Methamphetamine Use: A Global Perspective||p. 6|
|Basic Neuropharmacological Mechanisms of Methamphetamine||p. 30|
|Methamphetamine and the Brain: Findings from Brain Imaging Studies||p. 61|
|Behavioral Pharmacology and Psychiatric Consequences of Methamphetamine||p. 92|
|Medical Effects of Methamphetamine Use Larissa Mooney||p. 117|
|Public Health Issues Surround... MORE||p. 143|
|Methamphetamine and Crime||p. 157|
|Effects of Methamphetamine on Communities||p. 172|
|Psychosocial and Behavioral Treatment of Methamphetamine Dependence||p. 185|
|Pharmacological Treatment of Methamphetamine Addiction||p. 202|
|Treatment of Methamphetamine Addiction That Co-Occurs with Serious Mental Illness||p. 230|
|Table of Contents provided by Ingram. All Rights Reserved.|
John M. Roll, PhD, is Professor and Associate Dean for Research at Washington State University College of Nursing in Spokane and Director of its Program of Excellence in the Addictions. He is a Fellow of the American Psychological Association, President of the association's Division on Psychopharmacology and Substance Abuse, and was a vice-chairman of the Washington State Governor’s Council on Substance Abuse. Dr. Roll has received research funding from federal, state, and local sources, as well as foundation and industry support.
Richard A. Rawson, PhD, is Associate Director of the UCLA Integrated Substance Abuse Programs, one of the foremost substance abuse research groups, and Professor-in-Residence in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at the University of California, Los Angeles. Dr. Rawson oversees clinical trials on pharmacological and psychosocial addiction treatments. He served on the Federal Methamphetamine Advisory Group from 1996 to 1999.
Walter Ling, MD, is a board-certified neurologist and psychiatrist, Professor- in-Residence of Psychiatry at the David Geffen School of Medicine at the University of California, Los Angeles, and Director of the UCLA Integrated Substance Abuse Programs. He is a consultant for numerous local, national, and international private and public agencies. Dr. Ling's current research program is designed to bring cutting-edge findings from treatment research to practice in community treatment programs.
Steven Shoptaw, PhD, is Professor of Family Medicine and of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at the University of California, Los Angeles. Dr. Shoptaw’s research involves developing and implementing efficacious treatments for individuals with various drug dependence problems, particularly for those with stimulant dependence and risks for HIV infection and other health care problems.